Effect of plasma of patients recovered from covid-19 versus control group on treatment of covid-19

Phase 2

Recruiting

• Conditions: COVID-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20120215009014N353
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Age of 18 to 65 years,
Moderate to severe covid-19 disease,

Exclusion Criteria

Pregnancy,
IGA deficiency

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dyspnea. Timepoint: Every day for 3 weeks. Method of measurement: With taking history and physical examination.;Fever. Timepoint: Every day for 3 weeks. Method of measurement: With physical examination.;Cough. Timepoint: Every day for 3 weeks. Method of measurement: With taking history.